Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Medtronic
Federal Trade Commission
Cipla
Dow
Moodys
Cerilliant
Harvard Business School
Chinese Patent Office

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,656,650

« Back to Dashboard

Summary for Patent: 5,656,650
Title: Angiotensin II receptor blocking compositions
Abstract:This invention relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier, an angiotensin II receptor antagonist and a second agent selected from a diuretic, a calcium channel blocker, a .beta.-adrenoceptor blocker, a renin inhibitor, or an angiotensin converting enzyme inhibitor and a method of treating hypertension.
Inventor(s): Weinstock; Joseph (Phoenixville, PA)
Assignee: SmithKline Beecham Corp. (
Application Number:08/444,121
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 5,656,650

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,656,650

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 177634 ➤ Try a Free Trial
Australia 656551 ➤ Try a Free Trial
Australia 9178291 ➤ Try a Free Trial
Canada 2098176 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Medtronic
Teva
Federal Trade Commission
Fish and Richardson
Moodys
Queensland Health
Argus Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.